undefined undefined
NaN.000
NaN.00%
USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER...
05-15 23:14
ABVC BioPharma (NASDAQ:ABVC) said on Wednesday that together with its affiliate Rgene, it had entered into a comprehensive licensing agreement with OncoX. The company expects the agreement to facilita...
04-17 21:19
ABVC BioPharma (NASDAQ:ABVC) shares rise about 14% after it said that the company and affiliates entered into a term sheet with OncoX BioPharma for the company's Oncology/Hematology pipeline. This lic...
04-10 21:23
Gainers: Adial Pharmaceuticals (ADIL) +127%. Meiwu Technology Company (WNW) +73%. Nano Labs (NA) +42%. SolarBank Corporation (SUUN) +23%. iCoreConnect (ICCT) +23%. ABVC BioPharma (ABVC) +14% Exec...
04-10 21:17
ADIL: 108% | Adial Pharmaceuticals shares are trading higher after the company announced the publication of a peer-reviewed article highlighting the clinical results, strong safety profile, and high compliance
04-10 20:39
ABVC BioPharma said that the licensing agreement includes the ophthalmology pipeline, including the medical device Vitargus licensed products' and clinical trial, registration, manufacturing, supply, and distribution rights.
03-27 00:23
Gainers: Stoke Therapeutics (STOK) +79%. Mesoblast ADR (MESO) +29%. ABVC BioPharma (ABVC) +31%. Praxis Precision Medicines (PRAX) +25%. Check-Cap (CHEK) +23%. Losers: NeuBase Therapeutics (NBSE) -54%....
03-26 22:00
ABVC BioPharma, Inc. (NASDAQ:ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, today
02-27 21:45
FREMONT, CA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – A...
02-27 09:30
ABVC BioPharma's (NYSE:ABVC) short percent of float has risen 696.3% since its ...
01-26 04:45